Citigroup Initiates Coverage of Cardinal Health (CAH) with Neutral Recommendation

On March 31, 2023,
Citigroup
initiated coverage of Cardinal Health with
a Neutral recommendation.

Analyst Price Forecast Suggests 15.89% Upside

As of March 30, 2023,
the average one-year price target for Cardinal Health is $87.32.
The forecasts range from a low of $76.76 to a high of $98.70.
The average price target represents an increase of 15.89% from its latest reported closing price of $75.35.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for Cardinal Health
is $201,265MM, an increase of 4.28%.

The projected annual non-GAAP EPS
is $5.37.

What are Large Shareholders Doing?

VTSMX – Vanguard Total Stock Market Index Fund Investor Shares
holds 7,963K shares

representing 3.09% ownership of the company.

In it’s prior filing, the firm reported owning 8,123K shares, representing
a decrease
of 2.01%.

The firm

increased

its portfolio allocation in CAH by 4.36% over the last quarter.

VIMSX – Vanguard Mid-Cap Index Fund Investor Shares
holds 6,105K shares

representing 2.37% ownership of the company.

In it’s prior filing, the firm reported owning 6,269K shares, representing
a decrease
of 2.68%.

The firm

increased

its portfolio allocation in CAH by 3.12% over the last quarter.

VFINX – Vanguard 500 Index Fund Investor Shares
holds 6,057K shares

representing 2.35% ownership of the company.

In it’s prior filing, the firm reported owning 6,178K shares, representing
a decrease
of 2.01%.

The firm

increased

its portfolio allocation in CAH by 4.12% over the last quarter.

Geode Capital Management
holds 5,369K shares

representing 2.08% ownership of the company.

In it’s prior filing, the firm reported owning 5,447K shares, representing
a decrease
of 1.46%.

The firm

increased

its portfolio allocation in CAH by 5.05% over the last quarter.

Price T Rowe Associates
holds 4,994K shares

representing 1.94% ownership of the company.

In it’s prior filing, the firm reported owning 8,202K shares, representing
a decrease
of 64.23%.

The firm

decreased

its portfolio allocation in CAH by 31.07% over the last quarter.

What is the Fund Sentiment?

There are 1726 funds or institutions reporting positions in Cardinal Health.

This is an increase
of
111
owner(s) or 6.87% in the last quarter.

Average portfolio weight of all funds dedicated to CAH is 0.36%,
an increase
of 4.08%.

Total shares owned by institutions decreased
in the last three months by 5.41% to 246,047K shares.

The put/call ratio of CAH is 0.42, indicating a

bullish
outlook.

Cardinal Health Background Information
(This description is provided by the company.)

Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With 50 years in business, operations in 46 countries and approximately 48,000 employees globally, Cardinal Health is essential to care.

This story originally appeared on Fintel.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.